Challenges of Viable Delivery Systems for Therapeutic Peptides

THERAPEUTICS PEPTIDES DELIVERY

24-25 April 2017, London

 

Peptide delivery represents a highly debated area of scientific research that is currently receiving lots of attention. In the past few years, peptides were administered via injections, but the industry is now increasingly aware of the significance of the oral route due to higher levels of patient acceptance. The advances in oral technologies are opening new doors and approaches to administer peptides via the oral route, making researchers keen to explore this area further.

 

Our highly anticipated 4th Annual Peptides Congress provides a unique platform for scientists wanting to learn more about oral peptide delivery, with a special focus on non-invasive routes of administration of peptides as well as those improved technologies that are progressing currently to the clinic. In particular Joël Richard from Ipsen will present an extremely relevant topic on "Advances In Non-invasive Routes of Administration of Peptides: Focus on Successful Oral Technologies Progressing in the Clinic and Future Challenges".

 

See Agenda with speakers & presentations.

 

3 Interactive Streams:

▼ Recent Progress in Peptide Technologies & Manufacturing

▼ Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery

▼ Advances in Peptide Therapeutics

 

Free Webinar:Advances in Peptides Science   Register For Free Today   Speaker: Joël Richard, Senior Vice President, Peptides, Head of CMC Development Dreux Site, Ipsen Advances in Non-Invasive Routes of Administration of Peptides: Focus on Successful Oral Technologies Progressing in The Clinic & Future Challenges

 

Speakers Include:

 

Sponsors Include:

 

Related link：4th Annual Peptides Congress